UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Xeroderma Pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms

Abeti, R; Zeitberger, A; Peelo, C; Fassihi, H; Sarkany, RPE; Lehmann, AR; Giunti, P; (2018) Xeroderma Pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms. British Journal of Pharmacology 10.1111/bph.14557. (In press).

[img] Text
Abeti_et_al-2018-British_Journal_of_Pharmacology.pdf - ["content_typename_Accepted version" not defined]
Access restricted to UCL open access staff until 1 December 2019.

Download (627kB)

Abstract

Xeroderma Pigmentosum (XP) encompasses a group of rare diseases characterised in most cases by nucleotide excision repair (NER) malfunction, resulting in an increased sensitivity to ultraviolet radiation in affected individuals. Approximately 25-30% of XP patients present with neurological symptoms, such as sensorineural deafness, mental deterioration, and ataxia. Although it is known that dysfunctional DNA repair is the primary pathogenesis in XP, growing evidence suggests that mitochondrial pathophysiology may also occur. This appears to be secondary to dysfunctional NER but may contribute to the neurodegenerative process in these patients. The available pharmacological treatments in XP mostly target the dermal manifestations of the disease. In the present review, we outline how current understanding of the pathophysiology of XP could be used to develop novel therapies to counteract the neurological symptoms. Moreover, the coexistence of cancer and neurodegeneration present in XP, lead us to focus on possible new avenues targeting mitochondrial pathophysiology.

Type: Article
Title: Xeroderma Pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms
Location: England
DOI: 10.1111/bph.14557
Publisher version: https://doi.org/10.1111/bph.14557
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: http://discovery.ucl.ac.uk/id/eprint/10063302
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item